Chicago, IL --- Members of Harness Horsemen International today unanimously agreed to support the Sept. 25 decision by the Executive Committee of the United States Trotting Association to reject The Association of Racing Commissioners International proposed model medication rules, and to withdraw the USTA membership from the Racing Medication and Testing Consortium, Inc.
The harness racing industry has provided more than $1 million in funding to the RMTC in the past decade. The consensus from the USTA is that while they support uniform medication policies, breed customization should be mandatory, given that the breed characteristics between Standardbreds, Thoroughbreds and Quarter horses are significantly different.
“We believe the money can be better spent on research and testing in areas more concentrated on harness racing,” USTA President Phil Langley stressed. “We believe both breeds, Standardbreds and Thoroughbreds, will benefit from having rules concentrated solely on their needs. Trying to fit them together makes little sense.”
“We work closely with the USTA,” confirmed HHI President Tom Luchento. “We are in full agreement with the decisions they have made regarding this issue.”
The USTA, with the combined support of Harness Horsemen International and Harness Tracks of America, will ask RCI to maintain the current rules in effect for Standardbreds, instead of having one set of model rules for two breeds with significantly different requirements.